Polyrizon nasal protective gel blocks viruses and allergens
2026-09-07 08:00Products & Apps🔥 40.2 heat score
1sources
1days unfolding
40.2heat score
1mentions
SummaryAI generated
Polyrizon, a US-based developer of nasal gels, has announced the launch of a preventive nasal spray product based on the Capture and Contain™ (C&C) hydrogel platform. This product uses natural ingredients to create a physical barrier in the nasal cavity, aimed at blocking COVID-19, influenza viruses, and allergens. It is suitable for daily protection. This technology emphasizes a physical interception mechanism without the need for additional drug components, aiming to fill the market gap in non-pharmaceutical active protection of the upper respiratory tract. Currently, the product is in the pre-clinical validation and registration preparation stages.
Polyrizon, the developer of nasal gels, has announced the launch of a preventive nasal spray based on the Capture and Contain™ hydrogel platform. This product uses natural ingredients to form a physical barrier in the nasal cavity to block COVID-19, influenza viruses, and allergens. The technology is suitable for daily protection without the need for medicinal ingredients, emphasizing a physical blocking mechanism. The company is headquartered in the United States and is currently in the pre-clinical validation and registration preparation phase. This move aims to fill the market gap in non-pharmaceutical active protection of the upper respiratory tract.